NCT06023160View on ClinicalTrials.gov

Predicting Functional Outcome and Response to Therapy of Anti-NMDAR Encephalitis at Diagnosis

CompletedOBSERVATIONAL
Enrollment

714

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

July 1, 2023

Study Completion Date

July 1, 2024

Conditions
Anti-NMDA (N-Methyl D-Aspartate) Receptor Encephalitis
Trial Locations (1)

Unknown

Erasmus Medical Center, Rotterdam

Sponsors
All Listed Sponsors
lead

Erasmus Medical Center

OTHER